JOHN F. CARPENTER,1 THEODORE W. RANDOLPH,2 WIM JISKOOT,3 DAAN J.A. CROMMELIN,4 C. RUSSELL MIDDAUGH,5 GERHARD WINTER,6 YING-XIN FAN,7 SUSAN KIRSHNER,7 DANIELA VERTHELYI,7 STEVEN KOZLOWSKI,8 KATHLEEN A. CLOUSE,9 PATRICK G. SWANN,9 AMY ROSENBERG,7 BARRY CHERNEY7
1Department of Pharmaceutical Sciences, Center for Pharmaceutical Biotechnology, Box 238, University of Colorado Health Sciences Center, Denver, Colorado 80262
2Department of Chemical and Biological Engineering, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder, Colorado 80309
3Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Leiden University, Leiden, The Netherlands
4Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
5Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047
6Department of Pharmacy, Ludwig Maximilians University, 81377 Munich, Germany
7Division of Therapeutic Proteins, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, Maryland 20857
8Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, Maryland 20857
9Division of Monoclonal Antibodies, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, Maryland 20857
PUBLICATION: Journal of Pharmaceutical Sciences. 98(4): 1201-1205. (2009)
DOI 10.1002/jps.21530
LINK TO ARTICLE: http://onlinelibrary.wiley.com/doi/10.1002/jps.21530/abstrac
